Taylor R. Jamieson

Ontario Institute for Cancer Research — Canada

Medicine · Health Sciences

10h-index273citations23works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(13), Virus-based gene therapy research(9), COVID-19 Clinical Research Studies(4), Animal Virus Infections Studies(4), RNA Interference and Gene Delivery(3)

Publications23 total

Optimal delivery of RNA interference by viral vectors for cancer therapy
Molecular Therapy·2023· 37 citedOpen Access
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
Molecular Therapy — Methods & Clinical Development·2023· 11 citedOpen Access
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development
Journal of Biological Chemistry·2023· 5 citedOpen Access
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment
Frontiers in Immunology·2023· 12 citedOpen Access
Arming Vesiculovirus with SARS-CoV2 Spike Protein Creates a Murine Model of Severe COVID-19 ARDS
2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Nature Communications·2022· 46 citedOpen Access
17: ARMING VESICULOVIRUS WITH SARS-COV-2 S-PROTEIN CREATES A MURINE MODEL OF SEVERE COVID-19 ARDS
Critical Care Medicine·2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
Molecular Therapy·2021· 23 citedOpen Access
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021· 2 cited
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Journal of Visualized Experiments·2021
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Journal of Visualized Experiments·2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
Nanomaterials·2021· 11 citedOpen Access
Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
International Journal of Molecular Sciences·2021· 32 citedOpen Access
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
Molecular Therapy·2021· 26 citedOpen Access
Characterization of Critical Determinants of ACE2-RBD Interaction
2021Open Access
Riboswitch-Associated Guanidinium-Selective Efflux Pumps Frequently Transmitted on Proteobacterial Plasmids Increase Escherichia coli Biofilm Tolerance to Disinfectants
Journal of Bacteriology·2020· 21 citedOpen Access
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
Cytokine & Growth Factor Reviews·2020· 10 cited
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
Membranes·2020· 24 citedOpen Access
Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry
2020· 6 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Carolina S. Ilkow(20), Joanna Poutou(15), Taha Azad(15), Mathieu J. F. Crupi(12), Ragunath Singaravelu(12), Reza Rezaei(11), John C. Bell(10), Abera Surendran(9), Jean‐Simon Diallo(9), Zaid Taha(8), Stephen Boulton(8), Bradley Austin(7), Nikolas T. Martin(7), Adrian Pelin(6), Jaahnavi Dave(6), Julia Petryk(5), Sarah Tucker(5), Mina Ghahremani(5), Xiaohong He(4), Rozanne Arulanandam(4)